scholarly article | Q13442814 |
P356 | DOI | 10.1507/ENDOCRJ.52.471 |
P698 | PubMed publication ID | 16127217 |
P2093 | author name string | Kentaro Yamada | |
Yuji Hiromatsu | |||
Hiroo Kaku | |||
Ikuyo Miyake | |||
Michiko Ichimura | |||
Tokunori Mukai | |||
Tomoka Fukutani | |||
P433 | issue | 4 | |
P921 | main subject | Graves' disease | Q50357588 |
P304 | page(s) | 471-477 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Endocrine Journal | Q5376304 |
P1476 | title | A C/T polymorphism in the 5' untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. | |
P478 | volume | 52 |
Q38303947 | A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. |
Q36843735 | A novel polymorphism of the human CD40 receptor with enhanced function |
Q54443448 | Association analysis of CD40 gene polymorphism with acute coronary syndrome. |
Q39207119 | Association and linkage studies of the 20q11.2 region (GRD-2 locus) with Graves' disease in the Tunisian population. |
Q47106250 | Association between CD40 rs1883832 and immune-related diseases susceptibility: A meta-analysis |
Q64298501 | Association between the CD40 rs1883832 polymorphism and Graves' disease risk: a meta-analysis |
Q56898278 | CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population |
Q39120292 | CD40 Signaling in Graves Disease Is Mediated Through Canonical and Noncanonical Thyroidal Nuclear Factor κB Activation |
Q31161376 | Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases |
Q37032887 | Genetic developments in autoimmune thyroid disease: an evolutionary process |
Q35661517 | Genetic factors of autoimmune thyroid diseases in Japanese |
Q34171280 | Genetic susceptibility to autoimmune thyroid disease: past, present, and future |
Q36218526 | Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. |
Q37358260 | Genetics of rheumatoid arthritis: GWAS and beyond. |
Q35731002 | Graves' ophthalmopathy: a review of immunogenetics |
Q36236762 | Immunogenetics of autoimmune thyroid diseases: A comprehensive review |
Q34149621 | Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis |
Q37017200 | Recent insights into the pathogenesis and management of thyroid-associated ophthalmopathy |
Q36830207 | Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack? |
Q24673258 | The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future |
Q33307633 | The candidate genes TAF5L, TCF7, PDCD1, IL6 and ICAM1 cannot be excluded from having effects in type 1 diabetes |
Q36579326 | The etiology of autoimmune thyroid disease: a story of genes and environment |
Q35730994 | The genetic basis of graves' disease |
Q52601414 | The relationship between CD40 gene polymorphism and unstable coronary atherosclerotic plaques. |
Q54401140 | TheCD40Gene Polymorphism rs1883832 Is Associated with Risk of Acute Coronary Syndrome in a Chinese Case–Control Study |
Q91432480 | [New perspectives for the diagnosis and prognosis of Graves' disease] |
Search more.